Dr. Samantha Du is Founding Managing Director of Quan Capital. She is also Founder, Chairperson and Chief Executive Officer of Zai Lab. During her career, she has been a successful drug developer, entrepreneur, and investor.
After earning her Ph.D. in Biochemistry from the University of Cincinnati, Dr. Du joined Pfizer in the United States in the early 1990s. At Pfizer central research, she played a key role in the development of multiple early and late-stage products, two of which received U.S. FDA approval. She also led the scientific efforts of Pfizer’s global metabolic licensing group. Dr. Du co-founded Hutchison MediPharma (HMP) and Hutchison China MediTech (Chi-Med, now HUTCHMED), serving as Chief Executive Officer and Chief Scientific Officer, respectively. After more than a decade in these roles, she then joined Sequoia Capital China and led several landmark healthcare investment deals and served on multiple public and private boards. Dr. Du founded Zai Lab in 2014 and took the company public on the NASDAQ in 2017.
A recipient of numerous global awards and honors, Dr. Du is widely recognized as one of the biopharmaceutical industry’s most influential leaders.